US Patent No. 8,900,820

Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
Dec 04, 2014

Nuclea Biotechnologies has been awarded US Patent No. 8,900,820, "Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors."

Patrick Muraca is named as the inventor.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.